Kyntra Bio KYNB
NASDAQ KYNB
$7.52 +0.20 (+2.73%)
At close: Aug 21, 2026 · 4:00 PM EDT

Kyntra Bio (KYNB) Tax Rate Growth (3y) (2018 - 2026)

Kyntra Bio (KYNB) Tax Rate Growth (3y) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Kyntra Bio 30.42 Mn 30.42 Mn 1.47 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -27.00
Dec 31, 2025 8,334.00
Jun 30, 2025 70.00
Mar 31, 2025 17.00
Dec 31, 2024 6.00
Sep 30, 2024 -22.00
Jun 30, 2024 59.00
Mar 31, 2024 17.00
Dec 31, 2023 48.00
Sep 30, 2023 -78.00
Jun 30, 2023 46.00
Mar 31, 2023 -34.00
Dec 31, 2022 -9.00
Sep 30, 2022 3.00
Jun 30, 2022 -21.00
Mar 31, 2022 -23.00
Dec 31, 2021 -9.00
Sep 30, 2021 51.00
Jun 30, 2021 32.00
Mar 31, 2021 5.00